{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:50:49Z","timestamp":1792651849698,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.celrep.2019.01.069","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T10:39:04Z","timestamp":1549967944000},"page":"1718-1726.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pseudovirus rVSV\u0394G-ZEBOV-GP Infects Neurons in Retina and CNS, Causing Apoptosis and Neurodegeneration in Neonatal Mice"],"prefix":"10.1016","volume":"26","author":[{"given":"Ian L.","family":"McWilliams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Kielczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek D.C.","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Lewkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnamurthy","family":"Konduru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biying C.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chao","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel R.","family":"Caspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanraj","family":"Manangeeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Verthelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2019.01.069_bib1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2019.01.069_bib2","doi-asserted-by":"crossref","first-page":"e1002402","DOI":"10.1371\/journal.pmed.1002402","article-title":"Safety and immunogenicity of rVSV\u0394G-ZEBOV-GP Ebola vaccine in adults and children in Lambar\u00e9n\u00e9, Gabon: a phase I randomised trial","volume":"14","author":"Agnandji","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.celrep.2019.01.069_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jamaneurol.2017.1460","article-title":"Cerebrospinal fluid examination in survivors of ebola virus disease","volume":"74","author":"Billioux","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celrep.2019.01.069_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neuint.2011.02.020","article-title":"Viral infection and neural stem\/progenitor cell\u2019s fate: implications in brain development and neurological disorders","volume":"59","author":"Das","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.celrep.2019.01.069_bib5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0002-9440(10)63496-7","article-title":"Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease","volume":"163","author":"Feuer","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2019.01.069_bib6","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1523\/JNEUROSCI.4517-04.2005","article-title":"Coxsackievirus targets proliferating neuronal progenitor cells in the neonatal CNS","volume":"25","author":"Feuer","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2019.01.069_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2017.12.018","article-title":"The neonatal anti-viral response fails to control measles virus spread in neurons despite interferon-gamma expression and a Th1-like cytokine profile","volume":"316","author":"Ganesan","year":"2018","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.celrep.2019.01.069_bib8","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2019.01.069_bib9","doi-asserted-by":"crossref","first-page":"e1000225","DOI":"10.1371\/journal.ppat.1000225","article-title":"Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates","volume":"4","author":"Geisbert","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2019.01.069_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/07388551.2015.1114465","article-title":"Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead","volume":"37","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.celrep.2019.01.069_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2019.01.069_bib12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S1473-3099(17)30313-4","article-title":"Safety and immunogenicity of the rVSV\u0394G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study","volume":"17","author":"Heppner","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3201\/eid2408.171367","article-title":"Case Series of Severe Neurologic Sequelae of Ebola Virus Disease during Epidemic, Sierra Leone","volume":"24","author":"Howlett","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib14","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(16)30386-5","article-title":"Late Ebola virus relapse causing meningoencephalitis: a case report","volume":"388","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2019.01.069_bib16","article-title":"Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea","author":"Juan-Giner","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2019.01.069_bib17","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The Dual Nature of Type I and Type II Interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2019.01.069_bib18","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1016\/j.vaccine.2017.03.019","article-title":"Development of a micro-neutralization assay for ebolaviruses using a replication-competent vesicular stomatitis hybrid virus and a quantitative PCR readout","volume":"35","author":"Lee","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2019.01.069_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13054-016-1325-2","article-title":"Ebola virus disease and critical illness","volume":"20","author":"Leligdowicz","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.celrep.2019.01.069_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00479-17","article-title":"Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice","author":"Lennemann","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2019.01.069_bib21","doi-asserted-by":"crossref","first-page":"e1006004","DOI":"10.1371\/journal.ppat.1006004","article-title":"Zika (PRVABC59) Infection Is Associated with T\u00a0cell Infiltration and Neurodegeneration in CNS of Immunocompetent Neonatal C57Bl\/6 Mice","volume":"12","author":"Manangeeswaran","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2019.01.069_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41426-018-0096-z","article-title":"ZIKA virus infection causes persistent chorioretinal lesions","volume":"7","author":"Manangeeswaran","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2019.01.069_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3201\/eid2102.141649","article-title":"Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.celrep.2019.01.069_bib24","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1093\/infdis\/jiv188","article-title":"Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines","volume":"212","author":"Marzi","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2019.01.069_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1473-3099(15)00489-2","article-title":"Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study","volume":"16","author":"Mattia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.stem.2016.04.009","article-title":"Understanding How Zika Virus Enters and Infects Neural Target Cells","volume":"18","author":"Miner","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2019.01.069_bib28","doi-asserted-by":"crossref","first-page":"e1567","DOI":"10.1371\/journal.pntd.0001567","article-title":"Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates","volume":"6","author":"Mire","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clim.2016.10.016","article-title":"Ebola virus vaccines: where do we stand?","volume":"173","author":"Pavot","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2019.01.069_bib30","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.4049\/jimmunol.176.8.4940","article-title":"CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus","volume":"176","author":"Pedras-Vasconcelos","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2019.01.069_bib31","doi-asserted-by":"crossref","first-page":"10903","DOI":"10.1128\/JVI.74.23.10903-10910.2000","article-title":"Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1","volume":"74","author":"Rose","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2019.01.069_bib32","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/cid\/civ606","article-title":"Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement","volume":"61","author":"Sagui","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3201\/eid2204.151302","article-title":"Post-Ebola Syndrome, Sierra Leone","volume":"22","author":"Scott","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/mi.2010.6","article-title":"Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent","volume":"3","author":"Shirey","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.celrep.2019.01.069_bib35","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3201\/eid2307.161608","article-title":"Novel Retinal Lesion in Ebola Survivors, Sierra Leone, 2016","volume":"23","author":"Steptoe","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2019.01.069_bib36","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1080\/21645515.2018.1473698","article-title":"The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials","volume":"14","author":"Suder","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.celrep.2019.01.069_bib37","doi-asserted-by":"crossref","first-page":"e02154-16","DOI":"10.1128\/JVI.02154-16","article-title":"Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain","volume":"91","author":"van den Pol","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2019.01.069_bib38","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1523\/JNEUROSCI.3124-16.2017","article-title":"Zika Virus Targeting in the Developing Brain","volume":"37","author":"van den Pol","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2019.01.069_bib39","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola Virus in Ocular Fluid during Convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2019.01.069_bib40","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/JVI.79.6.3438-3447.2005","article-title":"Characterization of an in\u00a0vitro model of alphavirus infection of immature and mature neurons","volume":"79","author":"Vernon","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2019.01.069_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14712598.2018.1404572","article-title":"From bench to almost bedside: the long road to a licensed Ebola virus vaccine","volume":"18","author":"Wong","year":"2018","journal-title":"Expert Opin. Biol. Ther."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124719300981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124719300981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:34:28Z","timestamp":1761906868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124719300981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2211124719300981"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2019.01.069","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pseudovirus rVSV\u0394G-ZEBOV-GP Infects Neurons in Retina and CNS, Causing Apoptosis and Neurodegeneration in Neonatal Mice","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2019.01.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}